Lo más destacado Aprueba la FDA de Estados Unidos primer fármaco para la prevención de alergias accidentales a alimentos La Administración de Alimentos y Medicamentos (FDA) de Estados Unidos aprobó el anticuerpo monoclonal omalizumab en adultos y niños mayores de un año para reducir las reacciones alérgicas graves mediadas por inmunoglobulina […]
El Ozempic está de moda, y por razones de lo más tristes. En los últimos tiempos este fármaco indicado para el tratamiento de condiciones como la obesidad o la diabetes de tipo II ha adquirido fama por su uso fuera de pauta como adelgazante, a menudo reportado o incluso recomendado por distintas […]
The antiviral drug Paxlovid appears to reduce the risk of dying from COVID-19 by 79% and decrease hospitalizations by 73% in at-risk patients who are ages 65 and older, according to a new study published in The New England Journal of Medicine. The pill, which is a combination of the drugs nirmatrelvir and ritonavir, […]
Fluvoxamine — a selective serotonin reuptake inhibitor prescribed for various mental health disorders — has been proposed as a treatment for COVID-19, in part because of its putative anti-inflammatory effect. Observational data and a small randomized trial suggested benefit. Now, this drug has been tested in a placebo-controlled, adaptive platform […]
With the Delta variant of COVID-19 still raging in the United States and intensive care units in parts of the country filled with patients with the coronavirus, experts are voicing concern about the added risk of a difficult flu season. Two mathematical models are predicting a big rebound in the […]
